메뉴 건너뛰기




Volumn 14, Issue 3, 2015, Pages 649-658

The MDM2 inhibitor AMG 232 demonstrates robust antitumor efficacy and potentiates the activity of p53-inducing cytotoxic agents

Author keywords

[No Author keywords available]

Indexed keywords

AMG 232; CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; IDASANUTLIN; IRINOTECAN; LIGASE INHIBITOR; PROTEIN MDM2; PROTEIN P53; SAR 299155; UNCLASSIFIED DRUG; [2 (4 TERT BUTYL 2 ETHOXYPHENYL) 4,5 BIS(4 CHLOROPHENYL) 4,5 DIHYDRO 4,5 DIMETHYL 1H IMIDAZOL 1 YL][4 [3 (METHYLSULFONYL)PROPYL] 1 PIPERAZINYL]METHANONE; 2-(5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-(1-(ISOPROPYLSULFONYL)-3-METHYLBUTAN-2-YL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETIC ACID; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; CYTOTOXIN; MDM2 PROTEIN, HUMAN; PIPERIDONE DERIVATIVE; TP53 PROTEIN, HUMAN;

EID: 84942080824     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-14-0710     Document Type: Article
Times cited : (117)

References (18)
  • 3
    • 77955363995 scopus 로고    scopus 로고
    • TP53 mutations in human cancers: Origins, consequences, and clinical use
    • Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2010;2:a001008.
    • (2010) Cold Spring Harb Perspect Biol , vol.2 , pp. a001008
    • Olivier, M.1    Hollstein, M.2    Hainaut, P.3
  • 4
    • 0037317840 scopus 로고    scopus 로고
    • Inhibiting the p53-MDM2 interaction: An important target for cancer therapy
    • Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer 2003;3:102-9.
    • (2003) Nat Rev Cancer , vol.3 , pp. 102-109
    • Chene, P.1
  • 5
    • 18344377030 scopus 로고    scopus 로고
    • The p53 pathway: Positive and negative feedback loops
    • Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005;24:2899-908.
    • (2005) Oncogene , vol.24 , pp. 2899-2908
    • Harris, S.L.1    Levine, A.J.2
  • 8
    • 72549094296 scopus 로고    scopus 로고
    • An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals
    • Mohammad RM, Wu J, Azmi AS, Aboukameel A, Sosin A, Wu S, et al. An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals. Mol Cancer 2009;8:115.
    • (2009) Mol Cancer , vol.8 , pp. 115
    • Mohammad, R.M.1    Wu, J.2    Azmi, A.S.3    Aboukameel, A.4    Sosin, A.5    Wu, S.6
  • 9
    • 84876914265 scopus 로고    scopus 로고
    • MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancermodels
    • Tovar C, Graves B, Packman K, Filipovic Z, Higgins B, Xia M, et al. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancermodels. Cancer Res 2013;73:2587-97.
    • (2013) Cancer Res , vol.73 , pp. 2587-2597
    • Tovar, C.1    Graves, B.2    Packman, K.3    Filipovic, Z.4    Higgins, B.5    Xia, M.6
  • 11
    • 84880896065 scopus 로고    scopus 로고
    • Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development
    • Ding Q, Zhang Z, Liu JJ, Jiang N, Zhang J, Ross TM, et al. Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development. J Med Chem 2013;56:5979-83.
    • (2013) J Med Chem , vol.56 , pp. 5979-5983
    • Ding, Q.1    Zhang, Z.2    Liu, J.J.3    Jiang, N.4    Zhang, J.5    Ross, T.M.6
  • 12
    • 84896837973 scopus 로고    scopus 로고
    • Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development
    • Sun D, Li Z, Rew Y, Gribble M, Bartberger MD, Beck HP, et al. Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development. J Med Chem 2014;57: 1454-72.
    • (2014) J Med Chem , vol.57 , pp. 1454-1472
    • Sun, D.1    Li, Z.2    Rew, Y.3    Gribble, M.4    Bartberger, M.D.5    Beck, H.P.6
  • 13
    • 77955475709 scopus 로고    scopus 로고
    • Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growth
    • Carnahan J, Beltran PJ, Babij C, Le Q, RoseMJ, Vonderfecht S, et al. Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growth. Mol Cancer Ther 2010;9:2399-410.
    • (2010) Mol Cancer Ther , vol.9 , pp. 2399-2410
    • Carnahan, J.1    Beltran, P.J.2    Babij, C.3    Rose, M.J.4    Le Q5    Vonderfecht, S.6
  • 14
    • 84876147318 scopus 로고    scopus 로고
    • Inhibitors of the p53/hdm2 proteinprotein interaction-path to the clinic
    • Carry JC, Garcia-Echeverria C. Inhibitors of the p53/hdm2 proteinprotein interaction-path to the clinic. Bioorg Med Chem Lett 2013;23: 2480-5.
    • (2013) Bioorg Med Chem Lett , vol.23 , pp. 2480-2485
    • Carry, J.C.1    Garcia-Echeverria, C.2
  • 16
    • 0029821230 scopus 로고    scopus 로고
    • Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex
    • Poklar N, Pilch DS, Lippard SJ, Redding EA, Dunham SU, Breslauer KJ. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Proc Natl Acad Sci U S A 1996;93:7606-11.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , pp. 7606-7611
    • Poklar, N.1    Pilch, D.S.2    Lippard, S.J.3    Redding, E.A.4    Dunham, S.U.5    Breslauer, K.J.6
  • 17
    • 77954187741 scopus 로고    scopus 로고
    • DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
    • Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2012; 17:421-33.
    • (2012) Chem Biol , vol.17 , pp. 421-433
    • Pommier, Y.1    Leo, E.2    Zhang, H.3    Marchand, C.4
  • 18
    • 0033552595 scopus 로고    scopus 로고
    • Regulation of p53 in response to DNA damage
    • Lakin ND, Jackson SP. Regulation of p53 in response to DNA damage. Oncogene 1999;18:7644-55.
    • (1999) Oncogene , vol.18 , pp. 7644-7655
    • Lakin, N.D.1    Jackson, S.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.